197 related articles for article (PubMed ID: 19631303)
21. [Efficacy of strontium ranelate for the mineralization of bone in postmenopausal women].
Basurto L; Zárate A; Córdova N; Saucedo R; Galván R; Campos S; Hernández M
Ginecol Obstet Mex; 2009 May; 77(5):227-30. PubMed ID: 19496517
[TBL] [Abstract][Full Text] [Related]
22. Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial.
Monegal A; Guañabens N; Suárez MJ; Suárez F; Clemente G; García-González M; De la Mata M; Serrano T; Casafont F; Tome S; Barrios C; Navasa M
Transpl Int; 2009 Feb; 22(2):198-206. PubMed ID: 18796000
[TBL] [Abstract][Full Text] [Related]
23. Treatment with zoledronic acid ameliorates negative geometric changes in the proximal femur following acute spinal cord injury.
Shapiro J; Smith B; Beck T; Ballard P; Dapthary M; BrintzenhofeSzoc K; Caminis J
Calcif Tissue Int; 2007 May; 80(5):316-22. PubMed ID: 17417700
[TBL] [Abstract][Full Text] [Related]
24. Effect of endogenous estradiol levels on bone resorption and bone mineral density in healthy postmenopausal women: a prospective study.
Mastaglia SR; Bagur A; Royer M; Yankelevich D; Sayegh F; Oliveri B
Climacteric; 2009 Feb; 12(1):49-58. PubMed ID: 19003631
[TBL] [Abstract][Full Text] [Related]
25. Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2.
Henriksen DB; Alexandersen P; Byrjalsen I; Hartmann B; Bone HG; Christiansen C; Holst JJ
Bone; 2004 Jan; 34(1):140-7. PubMed ID: 14751571
[TBL] [Abstract][Full Text] [Related]
26. Feasibility of simultaneous measurement of bone formation and bone resorption markers to assess bone turnover rate in postmenopausal women: an EPOLOS study.
Łukaszkiewicz J; Karczmarewicz E; Płudowski P; Jaworski M; Czerwiński E; Lewiński A; Marcinowska-Suchowierska E; Milewicz A; Spaczyński M; Lorenc RS;
Med Sci Monit; 2008 Dec; 14(12):PH65-70. PubMed ID: 19043376
[TBL] [Abstract][Full Text] [Related]
27. Effects of soy protein isolate on bone mineral density and physical performance indices in postmenopausal women--a 2-year randomized, double-blind, placebo-controlled trial.
Vupadhyayula PM; Gallagher JC; Templin T; Logsdon SM; Smith LM
Menopause; 2009; 16(2):320-8. PubMed ID: 19169168
[TBL] [Abstract][Full Text] [Related]
28. Isosorbide mononitrate increases bone formation and decreases bone resorption in postmenopausal women: a randomized trial.
Jamal SA; Cummings SR; Hawker GA
J Bone Miner Res; 2004 Sep; 19(9):1512-7. PubMed ID: 15312252
[TBL] [Abstract][Full Text] [Related]
29. The effect of prior bisphosphonate exposure on the treatment response to teriparatide in clinical practice.
Middleton ET; Steel SA; Doherty SM
Calcif Tissue Int; 2007 Nov; 81(5):335-40. PubMed ID: 17938845
[TBL] [Abstract][Full Text] [Related]
30. Urinary osteocalcin and other markers of bone metabolism: the effect of risedronate therapy.
Kumm J; Ivaska KK; Rohtla K; Vaananen K; Tamm A
Scand J Clin Lab Invest; 2008; 68(6):459-63. PubMed ID: 18609099
[TBL] [Abstract][Full Text] [Related]
31. Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women.
Manonai J; Chittacharoen A; Udomsubpayakul U; Theppisai H; Theppisai U
Menopause; 2008; 15(3):530-5. PubMed ID: 18202589
[TBL] [Abstract][Full Text] [Related]
32. Vitamin K supplementation does not significantly impact bone mineral density and biochemical markers of bone in pre- and perimenopausal women.
Volpe SL; Leung MM; Giordano H
Nutr Res; 2008 Sep; 28(9):577-82. PubMed ID: 19083462
[TBL] [Abstract][Full Text] [Related]
33. Effects of lasofoxifene on bone in surgically postmenopausal cynomolgus monkeys.
Lees C; Shen V; Brommage R
Menopause; 2007; 14(1):97-105. PubMed ID: 17075430
[TBL] [Abstract][Full Text] [Related]
34. Relationship between bone turnover and bone density at the proximal femur in stroke patients.
Paker N; Bugdayci D; Tekdos D; Dere C; Kaya B
J Stroke Cerebrovasc Dis; 2009; 18(2):139-43. PubMed ID: 19251190
[TBL] [Abstract][Full Text] [Related]
35. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
[TBL] [Abstract][Full Text] [Related]
36. Reduction in bone resorption by exogenous glucagon-like peptide-2 administration requires an intact gastrointestinal tract.
Gottschalck IB; Jeppesen PB; Holst JJ; Henriksen DB
Scand J Gastroenterol; 2008 Aug; 43(8):929-37. PubMed ID: 19086164
[TBL] [Abstract][Full Text] [Related]
37. The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease.
Brown JE; McCloskey EV; Dewar JA; Body JJ; Cameron DA; Harnett AN; Ruutu M; Purohit OP; Tähtelä R; Coleman RE
Calcif Tissue Int; 2007 Nov; 81(5):341-51. PubMed ID: 17874331
[TBL] [Abstract][Full Text] [Related]
38. The influence of smoking on bone loss and response to nasal estradiol.
Bjarnason NH; Nielsen TF; Jørgensen HL; Christiansen C
Climacteric; 2009 Feb; 12(1):59-65. PubMed ID: 19058059
[TBL] [Abstract][Full Text] [Related]
39. Effect of long-term intervention of soy isoflavones on bone mineral density in women: a meta-analysis of randomized controlled trials.
Liu J; Ho SC; Su YX; Chen WQ; Zhang CX; Chen YM
Bone; 2009 May; 44(5):948-53. PubMed ID: 19168161
[TBL] [Abstract][Full Text] [Related]
40. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study.
Strokosch GR; Friedman AJ; Wu SC; Kamin M
J Adolesc Health; 2006 Dec; 39(6):819-27. PubMed ID: 17116511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
